camrelizumab immune checkpoint inhibitor investigated hepatocellular carcinoma hodgkin drug developed jiangsu hengrui medicine co ltd camrelizumab undergoing phase iiiii trials immune activation dostarlimab ibalizumab monoclonal article stub help wikipedia expanding httpsenwikipediaorgwikicamrelizumab